Rchr
J-GLOBAL ID：201801011330470887
Update date: Sep. 25, 2024
Eguchi Masamichi
エグチ マサミチ | Eguchi Masamichi
Affiliation and department：
Research field (1)：
Cardiology
Research keywords (2)：
Regenerative medicine
, Cardiovascular Medicine
Research theme for competitive and other funds (7)：
- 2022 - 2025 メタボローム解析を用いた肺動脈性肺高血圧症のバイオマーカの網羅的探索
- 2022 - 2025 好中球活性化に着目した強皮症合併肺高血圧症の早期診断・治療標的の包括的同定と展開
- 2021 - 2024 Role of long noncoding RNA in the pulmonary artery hypertension
- 2020 - 2023 スキャフォールドフリーの3次元構造体による機能を有する人工尿管の作成
- 2019 - 2022 Elucidation of the relationship of novel apoptosis-inducing substances to the pathophysiology of pulmonary arterial hypertension
- 2016 - 2019 Comprehensive Searching for Circulating mircoRNAs as a Novel Biomarker for Pulmonary Arterial Hypertension
- 2014 - 2016 Development of micro-RNA based Adipose-derived regenerative cell therapy for pulmonary arterial hypertension
Show all
Papers (19)：
-
Yuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, Tomohiro Honda, Masaya Kurobe, Ryohei Akashi, Tsuyoshi Yonekura, Tsuyoshi Yoshimuta, Masamichi Eguchi, Hiroaki Kawano, et al. The Authors' Reply to "Efficacy and feasibility of edoxaban therapy without prior parenteral anticoagulants in patients with venous thromboembolism". Internal medicine (Tokyo, Japan). 2024
-
Rosy Haruna Nishizawa, Hiroaki Kawano, Tsuyoshi Yoshimuta, Chisa Eguchi, Sanae Kojima, Takako Minami, Daisuke Sato, Masamichi Eguchi, Shinji Okano, Satoshi Ikeda, et al. Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis. European heart journal. Cardiovascular Imaging. 2023
-
Yuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, Tomohiro Honda, Masaya Kurobe, Ryohei Akashi, Tsuyoshi Yonekura, Tsuyoshi Yoshimuta, Masamichi Eguchi, Hiroaki Kawano, et al. Real-world Safety and Effectiveness of Edoxaban in Patients with Venous Thromboembolism with or without Preceding Parenteral Anticoagulants: A Single-center Retrospective Study. Internal medicine (Tokyo, Japan). 2023
-
Hiroaki Kawano, Koichi Kawamura, Mitsuaki Ishijima, Kuniko Abe, Tomayoshi Hayashi, Masamichi Eguchi, Kiyonori Miura, Koji Maemura. Pathological features of biopsied myocardium in patients clinically diagnosed with peripartum cardiomyopathy. Medical molecular morphology. 2023. 56. 1. 58-68
-
Yuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, Tomohiro Honda, Masaya Kurobe, Ryohei Akashi, Tsuyoshi Yonekura, Tsuyoshi Yoshimuta, Masamichi Eguchi, Hiroaki Kawano, et al. Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism - A Single-Center Retrospective Study. Circulation reports. 2022. 4. 11. 533-541
ｍore...
MISC (34)：
-
Eguchi Masamichi, Ikeda Satoshi, Honda Tomohiro, Ueno Yuki, Kawano Hiroaki, Maemura Koji. エサキセレノンは肺動脈性肺高血圧症における病的肺血管リモデリングを抑制する(Esaxerenone Attenuates Pathological Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension). 日本循環器学会学術集会抄録集. 2023. 87回. OE09-4
-
砂河 孝行, 魏 碩俣, 佐藤 大輔, 江口 正倫, 池田 聡司, 河野 浩章, 前村 浩二. マクロファージ低酸素シグナルによる動脈硬化プラーク脆弱化機構. Anti-aging Science. 2019. 11. 1. 66-66
-
内田 真人, 河野 浩章, 砂河 孝行, 山方 勇樹, 米倉 剛, 江口 正倫, 吉牟田 剛, 南 貴子, 古賀 聖士, 恒任 章, et al. 透析高血圧症の原因として虚血性心疾患が考えられた1例. 日本高血圧学会臨床高血圧フォーラムプログラム・抄録集. 2019. 8回. 201-201
-
魏碩俣, 砂河孝行, 江口正倫, 佐藤大輔, 池田聡司, 河野浩章, 前村浩二. 低酸素環境によるマクロファージ機能制御機構. 血管. 2019. 42. 1. 56
-
魏 碩俣, 砂河 孝行, 江口 正倫, 佐藤 大輔, 池田 聡司, 河野 浩章, 前村 浩二. 低酸素環境によるマクロファージ機能制御機構. 血管. 2019. 42. 1. 56-56
ｍore...
Professional career (1)：
Association Membership(s) (1)：
Return to Previous Page
